Depletion of AADC activity in caudate nucleus and putamen of Parkinson’s disease patients; implications for ongoing AAV2-AADC gene therapy trial

• Agnieszka Ciesielska,

  Affiliation Department of Neurological Surgery, University of California San Francisco, San Francisco, CA, United States of America

  ⨯
• Lluis Samaranch,

  Affiliation Department of Neurological Surgery, University of California San Francisco, San Francisco, CA, United States of America

  ⨯
• Waldy San Sebastian,

  Affiliation Department of Neurological Surgery, University of California San Francisco, San Francisco, CA, United States of America

  ⨯
• Dennis W. Dickson,

  Affiliation Mayo Clinic, Jacksonville, FL, United States of America

  ⨯
• Samuel Goldman,

  Affiliation Department of Neurology, University of California San Francisco, San Francisco, CA, United States of America

  ⨯
• John Forsayeth,

  Affiliation Department of Neurological Surgery, University of California San Francisco, San Francisco, CA, United States of America

  ⨯
• Krystof S. Bankiewicz

  * E-mail: Krystof.Bankiewicz@ucsf.edu

  Affiliation Department of Neurological Surgery, University of California San Francisco, San Francisco, CA, United States of America

  ⨯